American Heart Association

Drug used for menorrhagia may prevent postpartum hemorrhageA drug that is low cost and easy to administer may help prevent maternal deaths, according to results of a randomized clinical trial. Plus: Does air pollution affect menstrual regularity? Also: According to a statement published by the American Heart Association (AHA), breast cancer patients may be at increased risk of cardiovascular disease (CVD).
No insurance is growing problem for heart patients, providersTwo new studies address the financial implications of unexpected major healthcare expenses for common cardiovascular conditions and procedures.
Federal program aimed at reducing readmissions raises concernsA new study has shocking findings about death rates in heart failure patients enrolled in the Hospital Readmissions Reduction Program.
Five questions for payers to ask when deciding coverage of genomic testsGenetics and genomics are starting to have an impact on cardiovascular care. Here’s what payers should consider when deciding whether to cover a gene expression test.
How providers, payers, employers should be fighting obesityBy addressing the root problem of obesity with structured programs, providers can help patients lose weight and very possibly avoid expensive chronic illnesses as a result. Employers and payers should incentivize healthy weight by paying for obesity care and treatment, potentially reaping substantial savings in the long term.
Statin prescribing varies in patients with diabetesWide variation exists in practice-level statin prescribing for patients with diabetes, according to a new study.
Entresto may prevent death in some heart failure patientsTimely and broad use of Entresto could prevent or postpone more than 28,000 US deaths per year among HFrEF patients, according to research in JAMA Cardiology.
Novartis signs on to value-based pricing for EntrestoHospitalizations represent up to 80 percent of the direct medical costs of heart failure; reducing heart failure hospitalizations can help bring down overall healthcare costs.
First guidelines for pediatric pulmonary hypertensionPediatric pulmonary hypertension (PH) can be difficult to spot, and a lack of research on this rare condition has resulted in a lack of evidence-based diagnosis and treatment guidance–until now. The American Heart Association and the American Thoracic Society have released new, extensive guidelines that task force members hope will pave the way for new research and continued development of care plans for pediatric PH patients.
Neonatal resuscitation guidelines: Updated for 2015The neonatal resuscitation section of the 2015 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care includes a number of new and modified recommendations.